Shenyang Xingqi Pharmaceutical Hits Day High with 7.38% Surge

Shenyang Xingqi Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 7.38% on June 29, 2026. The stock reached an intraday high of CNY 41.67, showcasing its strong market activity. This performance stands in contrast to the China Shanghai Composite, which only rose by 1.16% on the same day. Over the past week, Shenyang Xingqi has shown a robust increase of 11.9%, while the broader market has faced a decline of 2.14%. The company's one-month performance also reflects a positive trend, with a gain of 7.88% compared to a marginal increase of 0.13% in the China Shanghai Composite. Financial metrics indicate a solid foundation for the company, highlighted by a net profit growth of 41.48% and a remarkable operating cash flow of CNY 771.22 million. The return on equity stands at 34.62%, further emphasizing the company's strong financial health. With a market capitalization of CNY 9,788 million, Shenyang Xingqi continues to position itself as a notable player in the pharmaceuticals and biotechnology sector.